Volitionrx (VNRX) Share-based Compensation (2019 - 2025)
Volitionrx filings provide 9 years of Share-based Compensation readings, the most recent being -$132875.0 for Q4 2025.
- On a quarterly basis, Share-based Compensation fell 140.79% to -$132875.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 14.8% increase, with the full-year FY2025 number at $1.7 million, up 37.14% from a year prior.
- Share-based Compensation hit -$132875.0 in Q4 2025 for Volitionrx, down from $812045.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $915031.0 in Q1 2022 to a low of -$132875.0 in Q4 2025.
- Median Share-based Compensation over the past 5 years was $537980.0 (2023), compared with a mean of $512705.1.
- The widest YoY moves for Share-based Compensation: up 290.32% in 2025, down 140.79% in 2025.
- Volitionrx's Share-based Compensation stood at $276729.0 in 2021, then surged by 155.21% to $706249.0 in 2022, then plummeted by 34.06% to $465734.0 in 2023, then tumbled by 30.06% to $325738.0 in 2024, then tumbled by 140.79% to -$132875.0 in 2025.
- The last three reported values for Share-based Compensation were -$132875.0 (Q4 2025), $812045.0 (Q2 2025), and $451374.0 (Q1 2025) per Business Quant data.